Isracann Biosciences Pitch Deck slide image

Isracann Biosciences Pitch Deck

12 The Team Darryl Jones, President & CEO Mr. Jones has over 15 years of capital market experience and an established financial network. Prior to joining Isracann in 2018, Mr. Jones was an Investment advisor with PI Financial Corp Canada and Raymond James Ltd Canada. He was responsible for raising significant risk capital for growth companies in all sectors, with a particular focus on medical cannabis and natural resources. Mr. Jones took True Leaf Medicine public in early 2014 at $10MM valuation and exited in 2016 at $150MM market capitalization. Matt Chatterton, COO Mr. Chatterton brings over 15 years of experience in the design, development and execution across a variety of projects and manufacturing operations. His expertise includes project management, facility management, logistics, supply side processes and procedures at a number of international manufacturing operations in Canada, China, Bulgaria, the Philippines and now in Israel. He is a Professional Engineer and graduate of Canada's Queens University with a Master's degree in Chemical Process Engineering (2003). Nitin Kaushal, Strategic Advisor Mr. Kaushal is a managing director with PwC in the Corporate Finance Practice in Toronto 25 years experience in the healthcare industry Mr. Kaushal has participated in capital market transactions ranging from private placements, IPO's, and bought deal underwritings in excess of $2B. He has been involved in over 40 M&A, strategic advisory & licensing assignments for a range of companies from early stage biotechs to large pharmas. Previously the Managing Director of leading healthcare investment banking teams in Canada, Mr. Kaushal was also awarded "Top-gun" investment banker in Canada for healthcare industry (Brendan Wood 2008/09). He was also previously Senior Investment Manager with MDS Capital Corp. responsible for sourcing, evaluating, and negotiating investments in US/Canadian healthcare companies. Mr. Kaushal holds a CA, CF qualifications from Canadian Institute of Chartered Accountants; BSc (Chemistry) University of Toronto. Desmond Balakrishnan, Director Partner, McMillan LLP, a commercial and business law firm since January 2004 isracann BIOSCIENCES
View entire presentation